Court of Appeals for the Federal Circuit April 29, 1998, 96-1463 (Nobelpharma Ab v. Implant Innovations, Inc.)
Also known as
United States · · · 29-04-1998
129 F.3d 1463 1997-2 Trade Cases P 71,973, 39 Fed.R.Serv.3d 402 NOBELPHARMA AB, Plaintiff/Counterclaim Defendant-Appellant, and Nobelpharma USA, Inc., Counterclaim Defendant-Appellant, and Per Ingvar Branemark and Institute For Applied Biotechnology, Counterclaim Defendants, v. IMPLANT INNOVATIONS, INC., Defendant Counterclaimant-Appellee. No. 96-1463. United States Court of Appeals, Federal Circuit. Nov. 18, 1997. Rehearing Denied; Suggestion for Rehearing In Banc Declined April 29, 1998. Donald R. Dunner, Finnegan, Henderson, Barabow, Garrett & Dunner, L.L.P., Washington, DC, argued for plaintiff/counterclaim defendant-appellant and counterclaim defendant-appellant. With him on the brief were Robert D. Bajefsky and David A. Manspeizer. Of counsel on the brief were Robert A. Bourque, Kathleen M. Scanlon, and Lawrence M. Young, Simpson, Thacher & Bartlett, New York City, and Alan I. Becker, Burditt & Radzius, Chartered, Chicago, IL. D. Dennis Allegretti, Burns & Levinson, LLP, Boston, MA, argued for the defendant counterclaimant-appellee. With him on the brief were Stephen G. Rudisill, Arnold, White & Durkee, and Edward L. Foote and Peter C. McCabe, III, Winston & Strawn, Chicago, IL. Before RICH, PLAGER, and LOURIE, Circuit Judges. Opinion for the court filed by Circuit Judge LOURIE. Concurring-in-part and dissenting-in-part opinion filed by Circuit Judge PLAGER. LOURIE, Circuit Judge. 1 Nobelpharma AB and Nobelpharma USA, Inc. (collectively, NP) appeal from the judgment of the United States District Court for the Northern District of Illinois holding that (1) U.S. Patent 4,330,891 is invalid under 35 U.S.C. § 112, p 1 (1994), for failure to disclose the best mode of carrying out the invention, (2) Implant Innovations, Inc. (3I) did not infringe the '891 patent, and (3) NP was not entitled to JMOL or, in the alternative, a new trial following the jury verdict in favor of 3I on its antitrust counterclaim against NP, Dr.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit